If you are grappling with the proposed DEA rules, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation, you are invited to utilize AAPPN’s new interactive webpage.
With this online tool, you can find a roadmap for prescribing controlled substances under the proposed DEA rules, including:
- Schedule III, IV, or V non-narcotic controlled medications
- Buprenorphine as medication for opioid use disorder
- Schedule II and/or narcotic controlled medications
In addition to the DEA prescriber guidelines, you will also find guidance on what you will need to maintain appropriate written or electronic patient logs.
If you wish to comment on the proposed DEA rules, please visit https://www.regulations.gov/document/DEA-2023-0029-0001. Comments must be received by 11:59 pm Eastern Standard Time, on March 31, 2003.
Our thanks to the AAPPN Telehealth Team for their work in coordinating this website feature. Our AAPPN volunteers and staff will make every effort to ensure that this interactive webpage remains up-to-date as changes take effect, including the potential audio-only rules and the sunset of the Public Health Emergency rules.
Please note that this online tool is intended as a reference only. AAPPN does not intend to provide legal advice. If you have any concerns about how your practice meets the DEA rules, be sure to contact DEA or an attorney.